Immune thrombocytopenia (ITP) occurs with an incidence rate of 1.6 to 3.9 per 100,000
patient-years, which increases with age and has a slight female preponderance. ITP is …

Platelet function testing is essential for the diagnosis of hemostasis disorders. While there
are many methods used to test platelet function for research purposes, standardization is …

Management of children with newly diagnosed immune thrombocytopenia (ITP) consists of
careful observation or immunomodulatory treatment. Observational studies suggest a lower …

Immune thrombocytopenia (ITP) patients with similarly low platelet counts differ in their
tendency to bleed. To determine if differences in platelet function in ITP patients account for …

Duchenne muscular dystrophy (DMD) is a progressive severe muscle‐wasting disease
caused by mutations in DMD, encoding dystrophin, that leads to loss of muscle function with …

This review evaluates the role of platelets in bleeding risk among patients with
hematological disease and thrombocytopenia. Platelets are pivotal in primary hemostasis …

Immune thrombocytopenia is a common bleeding disease caused by autoantibody-
mediated accelerated platelet clearance and impaired thrombopoiesis. Accumulating …

Evidence-based medicine is growing in immune thrombocytopenia (ITP), but solid clinical
data are still lacking in many areas. A majority of children has self-limited ITP, but chronic …

Background Platelet count alone does not reliably predict bleeding risk, suggesting platelet
function is important to monitor in patients with thrombocytopenia. There is still an unmet …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a significant
reduction in the number of circulating platelets which is frequently associated with bleeding …